Table 2: Studies on subclinical atherosclerosis in psoriatic arthritis.

YearCountryNo. of patientsNo. of controlsMale, no.Age, mean ± SDIMT, mm, PsAIMT, mm, controls valueCarotid plagues, no. (%), PsACarotid plagues, no. (%), controlsCarotid plagues, value

Gonzalez-Juanatey et al. [33]2007Spain595931 0.0319 (15)3 (5)0.068
Kimhi et al. [34]2007Israel4710024 Average IMT: ;
adjusted IMT*:
Average IMT: ;
adjusted IMT*: ;
Average IMT: <0.0001;
adjusted IMT*: 0.04
Eder et al. [47]2008Israel40401257.85 (43–76) 0.0328 (70)16 (40)<0.05
Tam et al. [32]2008Hong Kong828242 Average IMT: ;
maximum IMT:
Average IMT: ;
maximum IMT:
Average IMT: <0.001;
maximum IMT: <0.001
15 (18)0<0.001
Mazlan et al. [46]2009Malaysia632849.92 (13–74)
Atzeni et al. [31]2011Italy223512 NS

IMT: intima-media thickness; PsA: psoriatic arthritis; NS: not significant.
*Adjusted for age, hyperlipidemia, diabetes, and body mass index.
Mean (range).